Australia TGA ARTG record

Multiple-viruses IVDs

Australia TGA ARTG Registered Device · Nationwide Asset Management Consolidated Pty Ltd · Getein Biotech Inc · Class IIb · Started November 11, 2022

Good Name: Nationwide Asset Management Consolidated Pty Ltd - Multiple-viruses IVDs

Device classification

Risk Class: Class IIb
Product Type: IVD
ARTG Category: IVD

Registration information

Start Date: November 11, 2022
Effective Date: November 16, 2022

Sponsor

Name: Nationwide Asset Management Consolidated Pty Ltd

Manufacturer

Name: Getein Biotech Inc
Country: China
Address: No 9 Bofu Road Luhe District, Nanjing, Jiangsu, 211505

Intended purpose

Intended to detect Influenza A/B and the novel coronavirus SARS-CoV-2 from symptomatic individuals at the point of care by trained health professionals (nasal swab) and for self-testing by lay persons (nasal swab).

About this record

Access comprehensive regulatory information for Multiple-viruses IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Nationwide Asset Management Consolidated Pty Ltd, manufactured by Getein Biotech Inc in China. The device registration started on November 11, 2022.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.